U.S. Law On 12-Year Biologics Data Exclusivity Remains Stumbling Block To Trans-Pacific Partnership Agreement
This article was originally published in PharmAsia News
Executive Summary
Trans-Pacific Partnership proving to be a test case for Affordable Healthcare Act’s 12-year data exclusivity provision for biologics.